Pharmacokinetic behavior of micafungin in rats with carbon tetrachloride-induced acute hepatic failure

13Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

We examined the pharmacokinetic behavior of micafungin, a novel antifungal agent, in rats receiving carbon tetrachloride (CCl4) at a single dose of 2.5 ml/kg. There was no significant change in the total clearance (CL tot) in CCl4-treated rats, while the steady-state volume of distribution (Vdss) was significantly increased by CCl4 treatment. Alteration in the serum unbound fraction of micafungin after CCl4 treatment was unlikely in light of the serum albumin, bilirubin, creatinine, and urea nitrogen. The increased Vdss was attributable to augmentation in the accessibility of micafungin to peripheral tissue without impairment of the intrinsic clearance, because slight enhancement of the tissue distribution of micafungin was confirmed following CCl4 treatment. © 2005 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Konishi, H., Sudo, M., Sumi, M., Morii, H., Minouchi, T., Aimoto, T., & Yamaji, A. (2005). Pharmacokinetic behavior of micafungin in rats with carbon tetrachloride-induced acute hepatic failure. Biological and Pharmaceutical Bulletin, 28(3), 556–559. https://doi.org/10.1248/bpb.28.556

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free